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Abstract Adult T cell leukemia derived factor (ADF)/thio-
redoxin (Trx) is known to be an important intracellular
antioxidant involved in a number of redox reactions such as
ribonucleotide reductase (RNR) as well as of tyrosinase. Since
RNR is a key enzyme of nucleotide metabolism and DNA
synthesis, a reduced Trx level would result in reduced enzymatic
activity and cause DNA damage. Furthermore, Trx is considered
to be an effective regulator of redox sensitive gene expression.
The role of Trx in nucleotide metabolism and gene expression
may be an explanation for increased chromosomal instability as
well as hypersensitivity towards oxygen, ROI and ROI
generating agents. The activity of tyrosinase, the key enzyme
of melanin biosynthesis, is influenced by the thioredoxin level and
by superoxide radicals. Low thioredoxin levels and high super-
oxide concentrations activate tyrosinase causing hyperpigmenta-
tion of the skin. In addition to the observed high superoxide
concentration in Fanconi anemia (FA) patients, a low thioredox-
in level might be responsible for the hyperpigmentation (cafeŁ-au-
lait spots) in this disease. We observed that overexpression of the
thioredoxin cDNA in FA fibroblasts completely abolished the
DNA damaging effects of mitomycin C and diepoxybutane and
inhibited the constitutive activity of the nuclear factor UB (NF-
UB) in SV40 transformed FA fibroblasts. However, spontaneous
chromosomal breakage was not affected.
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1. Introduction
Fanconi anemia (FA) is an autosomal recessive disorder
characterized by progressive pancytopenia, multiple congeni-
tal abnormalities, a high risk of cancer, hyperpigmentation of
the skin and chromosomal instability [1,2]. Chromosomal in-
stability and hypersensitivity towards the DNA crosslinking
agents mitomycin C and diepoxybutane, substances that in-
crease the number of chromosomal breaks in FA cells but not
in cells from healthy individuals, suggest a molecular defect in
DNA repair [3]. However, no such defect in DNA repair has
been found [4^7].
Moreover, the recently cloned FA-A and FA-C proteins
have been localized to the cytoplasm. In addition, hypersensi-
tivity towards oxygen and increased ROI levels have been
shown in FA cells [8^11]. Furthermore, involvement of the
cytochrome P450 enzyme system in ROI generation and me-
diation of mitomycin C and diepoxybutane toxicity in FA
cells imply that a de¢cient DNA repair is not the primary
defect of this disease [7,12].
The abnormal oxygen metabolism of FA cells points to a
defective antioxidative mechanism. In FA ¢broblasts, how-
ever, antioxidative enzymes like catalase, superoxide dismu-
tase (SOD), glutathione reductase, and phospholipid hydro-
peroxide glutathione peroxidase (PHGPx) have been shown to
be normal [7,13]. On the other hand, antioxidants have been
shown to be bene¢cial for DNA stability and survival of FA
cells [7,14].
Thioredoxin is an intracellular antioxidant [15] and regula-
tor of redox sensitive gene expression [16] that may have im-
plications in FA cells. As a cofactor of the ribonucleotide
reductase it is necessary for DNA synthesis and DNA stability
[17,18]. Furthermore, it regulates the activity of tyrosinase
[19].
We investigated the e¡ect of the antioxidant thioredoxin on
FA cells. We hypothesized that reduced thioredoxin levels
would disturb redox dependent gene expression, in£uence nu-
cleotide metabolism resulting in increased chromosomal insta-
bility and would cause activation of tyrosinase resulting in
hyperpigmentation of the skin, features well documented in
FA [16,20^23].
2. Materials and methods
2.1. Cell lines and culture conditions
The FA cell line 1424 originates from a male patient and was
established and classi¢ed as FA-A by K. Sperling, Berlin. The control
cell line CoHe was established in our laboratory. Both derived from
lower arm punch biopsies. Cells were grown in minimum essential
medium (MEM-Eagle with Earle salts, Seromed) supplemented with
10% fetal calf serum (FCS; Life Technologies) without antibiotics at
37‡C in a 5% CO2 atmosphere and 90% humidity. Both strains were
routinely checked for mycoplasma infections.
2.2. Chemicals
All chemicals were purchased from Sigma or Roth unless otherwise
indicated. Electroporation cuvettes were from Bio-Rad laboratories.
Oligonucleotides were synthesized by TIB MolBiol, Berlin. Poly dI-dC
was from Pharmacia, Freiburg. Restriction enzymes were from Life
Technologies. Mitomycin C was from Boehringer Mannheim.
2.3. Transfection experiments
Cells were grown to con£uence, harvested by trypsinization, washed
twice with 5 ml HeBS bu¡er (20 mM HEPES pH 7.05, 137 mM NaCl,
5 mM KCl, 0.7 mM Na2HPO4, 6 mM D-glucose) and ¢nally resus-
pended in HeBS to a density of 1U106 cells/50 Wl and incubated for
10 min at room temperature. Cells were transferred to a 0.4 cm elec-
troporation cuvette, 10 Wg plasmid DNA was added and cells were
electroporated (200 V, 200 6 and 125 WFd) in a gene pulser from Bio-
Rad. Following electroporation cells were incubated for 10 min at
room temperature and ¢nally resuspended in MEM-Eagle with 15%
FCS and antibiotics. 200 ng/ml G418 was added to the growth me-
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dium 24 h after electroporation. For the NF-UB experiments cells
were collected 60 h after transfection. For stable integration of the
ADF gene the plasmid DNA was restricted with BglII. The cells were
grown with 200 ng/ml G418 for the whole culture period.
2.4. Micronucleus assay
For chromosomal instability determination the micronucleus tech-
nique was used [24]. Non-transfected and ADF transfected cells
seeded on glass slides were immediately treated with 20 ng/ml DEB
or 100 ng/ml MMC for 48 h. The cells were washed twice with PBS,
¢xed in ice-cold methanol, stained for 30 min with bis-benzimide (1
Wg/ml in PBS). Coverslips were mounted with a PBS/glycerol/distilled
water solution (3/1/1). 1000 cells per slide were scored for micronuclei
using a £uorescence microscope with phase contrast optics (Zeiss).
Mitotic cells were counted and the mitotic index was determined si-
multaneously.
2.5. Determination of cell viability
The MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium
bromide) assay was used to determine cell viability according to
Green et al. (1984) with minor modi¢cations. 5000 cells/well were
seeded in 24 multiwell plates and incubated for 24 h. After 24 h cells
were treated with DEB for 2 h or MMC for 1 h. Cells were washed
twice with PBS and incubated in growth medium for another 24 h.
For the last 4 h 100 Wl MTT (5 mg/ml stock solution PBS, sterile
¢ltered) per 1 ml growth medium was added. The medium was de-
canted, cells were washed twice with PBS and the formed formazan
dye was dissolved in 500 Wl ethanol (100%). The absorption of the
solution was measured at V570^V630 in a spectrophotometer (Beckman,
DU 650).
2.6. NF-UB detection
For NF-UB experiments 1U106 cells were transfected with the pCR/
CMV plasmid containing the ADF gene or an empty pCR/CMV
plasmid and ¢nally were seeded on plates (Costar, 10 cm diameter).
48 h after seeding, cells were harvested for nuclear extracts.
2.7. Preparation of nuclear extracts
Nuclear extracts were prepared as described [25,26]. Brie£y, mono-
layers were washed twice with TBS (Tris bu¡ered saline) pH 7.4, cells
collected by scraping and spinning in a microfuge. Pellets were resus-
pended in 400 Wl bu¡er A (10 mM HEPES pH 7.9; 10 mM KCl; 0.1
mM EDTA; 0.1 mM EGTA; 1 mM DTT; 0.5 mM PMSF; DTT and
PMSF were added just before use from a stock solution). Tubes were
placed on ice for 15 min, 25 Wl of 10% Nonidet NP 40 (Boehringer
Mannheim) was added and the tubes were vortexed for 10 s. Cell
homogenates were centrifuged for 30 s. Supernatants were removed
and pellets were resuspended in 30^50 Wl ice-cold bu¡er C (20 mM
HEPES pH 7.9; 400 mM NaCl; 1 mM EDTA; 1 mM EGTA; 1 mM
DTT; 1 mM PMSF), followed by vigorous shaking on an Eppendorf
mixer at 4‡C for 15 min. Extracts were centrifuged for 5 min in a
microfuge at 4‡C. Supernatants were frozen in liquid nitrogen and
stored at 380‡C. 5 Wg protein of the nuclear extract was used for
band shift assays. Protein content was determined as described (Brad-
ford, 1976), the reagent was obtained from Bio-Rad Laboratories
GmbH.
2.8. Electrophoretic mobility shift assay
EMSAs (electrophoretic mobility shift assays) were performed as
described [27]. Brie£y, 20 Wl binding reaction contained: 1.5 Wg poly
dI-dC; 1^2 ng 32P-labelled IgU oligo-probe (5000^10000 cpm Ceren-
kov); 10 Wl 2Ushift bu¡er (20 mM HEPES pH 8.4; 60 mM KCl; 8%
Ficoll; 0.03% Nonidet NP 40); 2 mg BSA; 5 Wg nuclear extract.
Binding reactions were started by adding the nuclear extracts and
performed for 30 min at 30‡C. Samples were analyzed on native 4%
polyacrylamide gels.
3. Results
An altered antioxidant status despite an intact antioxidant
defense system has been described as a possible cause of Fan-
coni anemia [13]. Antioxidants have been shown to have a
bene¢cial e¡ect on FA cells [7,14]. Thioredoxin is a small
but important cellular antioxidant whose e¡ect on FA cells
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Fig. 1. E¡ect of mitomycin C (200 ng/ml) and diepoxybutane (20
ng/ml) on micronucleus production of untransfected and ADF
transfected FA cells and control cells. Bars: means and standard de-
viations of 6^18 independent experiments.
Fig. 2. A: Survival rates of non-transfected and ADF transfected
FA and control cell lines treated with increasing amounts of mito-
mycin C (A) and diepoxybutane (B). Control cells : (a) not trans-
fected; (b) ADF transfected. FA cells: (E) not transfected; (F)
ADF transfected. Symbols: means of three separate experiments.
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has not been previously investigated. We investigated the ef-
fect of thioredoxin on chromosomal breakage and cell viabil-
ity in FA cells by overexpressing the thioredoxin protein by
means of the stably transfected thioredoxin cDNA carrying
plasmid pCR/CMV-ADF.
Overexpression of thioredoxin resulted in a decrease of
chromosomal breaks in MMC and DEB treated FA cells
(Fig. 1). And as shown by the MTT viability test the cytotoxic
e¡ect of these substances was also reduced (Fig. 2A,B). In
contrast, non-transfected FA cells and control cells showed
no such bene¢cial e¡ect in their survival ratio (Fig. 2A,B).
Also the rate of spontaneous chromosomal breaks was not
signi¢cantly reduced. The overexpression of thioredoxin was
measured by determination of NF-UB activity. NF-UB activity
becomes diminished at an increased thioredoxin level. Thus,
the measurement of NF-UB activity is a rather sensitive meth-
od to determine the overexpression of thioredoxin [28].
As shown previously by our laboratory, NF-UB, which is
induced by ROI, is constitutively activated in SV40 trans-
formed FA cell lines. This constitutive NF-UB activity could
be reduced by the addition of antioxidants [7]. To check
whether thioredoxin also reduces this NF-UB activity, we
overexpressed thioredoxin transiently in SV40 transformed
FA cell lines. An almost complete reduction of this constitu-
tive NF-UB activity was observed (Fig. 3).
4. Discussion
A defective antioxidative defense system has been discussed
as possible cause of Fanconi anemia. However, no di¡erences
in the activities of the antioxidative enzymes superoxide dis-
mutase, glutathione peroxidase, PHGPx and catalase were
found in FA. Likewise, the level of the intracellular antiox-
idant glutathione was una¡ected [7,13]. However, extracellu-
larly added antioxidants like DTT or desferrioxamine can
reduce the spontaneously raised level of chromosomal breaks
in FA cells [7,14,29]. This suggests a disturbed oxygen metab-
olism in FA cells may be operative.
The intracellular antioxidant thioredoxin is responsible for
optimal activity of ribonucleotide reductase and therefore es-
sential for DNA synthesis [17]. A defective thioredoxin mol-
ecule would therefore lead to a decreased activity of ribonu-
cleotide reductase and result in increased chromosomal
breakage, a characteristic feature of FA cells.
Thioredoxin is also considered to be an e¡ective regulator
of redox sensitive gene expression. Thus, a reduced thioredox-
in level may be responsible for increased DNA damage and
hypersensitivity of FA cells towards oxygen, because of the
inability to induce gene expression.
The activity of tyrosinase, an enzyme catalyzing the ¢rst
step in melanin biosynthesis, is thioredoxin dependent. Thio-
redoxin inhibits the activity of tyrosinase [20]. The absence of
thioredoxin causes a hyperactive tyrosinase activity that re-
sults in increased melanin biosynthesis and hyperpigmentation
of the skin, a typical feature of FA patients.
Thioredoxin is an important general antioxidative molecule
in the cell. A defective thioredoxin would theoretically lead to
an increase of the intracellular ROI level as found in FA cells.
The plasmid generated overexpression of the antioxidant
thioredoxin prevents the cytotoxic and genotoxic e¡ect of
these agents, but does not reduce the level of spontaneous
chromosomal breaks. Since antioxidants like DTT can reduce
induced as well as spontaneous chromosomal breaks [7,29],
we assume that the antioxidant thioredoxin is not able to
enter the nucleus in FA cells. The cytoplasmic action further
becomes obvious by the inhibition of the ROI dependent con-
stitutive NF-UB activity in SV40 transformed FA ¢broblasts.
Thus, thioredoxin detoxi¢es ROI in the cytoplasm, for exam-
ple ROI generated by redox cycling of MMC or DEB, but not
in the nucleus where ROI damages the DNA. The non-cellu-
lar antioxidant DTT, enabled to enter the nucleus, decreases
the amount of spontaneous chromosomal breaks. This fact
suggests that in consequence of the primary defect thioredoxin
may not enter the nucleus in FA. A disturbed physiological
oxidant-antioxidant homeostasis would follow, leading to in-
creased oxidative DNA damage and an altered gene expres-
sion.
Further experiments will show if translocation of thioredox-
in into the nucleus of FA cells in£uences the spontaneous
chromosomal instability.
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